Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Premature Coronary Atherosclerosis in Scleroderma

This study has been completed.
Sponsor:
Information provided by:
Tuen Mun Hospital
ClinicalTrials.gov Identifier:
NCT00372398
First received: September 5, 2006
Last updated: September 15, 2010
Last verified: September 2010
  Purpose

The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.


Condition
Scleroderma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Premature Coronary Atherosclerosis in Scleroderma: A Case Control Study

Resource links provided by NLM:


Further study details as provided by Tuen Mun Hospital:

Enrollment: 28
Study Start Date: October 2006
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

scleroderma patients

Criteria

Inclusion Criteria:

  1. Age >= 18 years.
  2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00372398

Locations
Hong Kong
Tuen Mun Hospital
Hong Kong, Hong Kong
Sponsors and Collaborators
Tuen Mun Hospital
Investigators
Principal Investigator: CC Mok, MD FRCP Tuen Mun Hospital, Hong Kong
  More Information

No publications provided

Responsible Party: CC Mok, Tuen Mun Hospital, Hong Kong
ClinicalTrials.gov Identifier: NCT00372398     History of Changes
Other Study ID Numbers: NTWC/CREC/429/06
Study First Received: September 5, 2006
Last Updated: September 15, 2010
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Tuen Mun Hospital:
scleroderma
sclerosis
atherosclerosis

Additional relevant MeSH terms:
Arteriosclerosis
Atherosclerosis
Coronary Artery Disease
Myocardial Ischemia
Scleroderma, Diffuse
Scleroderma, Localized
Scleroderma, Systemic
Arterial Occlusive Diseases
Cardiovascular Diseases
Connective Tissue Diseases
Coronary Disease
Heart Diseases
Skin Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on November 27, 2014